• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/28/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported that the stent was partially deployed and stretched.The 99% stenosed target lesion was located in a moderately tortuous and moderately calcified superficial femoral artery.A 7x120, 130 cm eluvia drug-eluting vascular stent system was selected to treat the peripheral arterial disease.Pre-dilation was performed properly; however, during the procedure, the stent was difficult to deploy.As a result, the stent was stretched.The original device was used to complete the procedure.No patient complications were reported.
 
Manufacturer Narrative
E1: initial reporter state- (b)(6).Device analysis by manufacturer: returned product consisted of an eluvia self-expanding stent system with an unknown 0.014 inch guidewire stuck in the device.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the sheath is kinked at the nosecone.Microscopic examination revealed no additional damages.The stent was deployed and did not return for analysis.The handle was x-rayed, and the proximal inner was prolapsed.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Event Description
It was reported that the stent was partially deployed and stretched.The 99% stenosed target lesion was located in a moderately tortuous and moderately calcified superficial femoral artery.A 7x120, 130 cm eluvia drug-eluting vascular stent system was selected to treat the peripheral arterial disease.Pre-dilation was performed properly; however, during the procedure, the stent was difficult to deploy.As a result, the stent was stretched.The original device was used to complete the procedure.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15267593
MDR Text Key302358906
Report Number2124215-2022-30576
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/14/2023
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0028675384
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/16/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/28/2022
Initial Date FDA Received08/22/2022
Supplement Dates Manufacturer Received08/27/2022
Supplement Dates FDA Received09/19/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/14/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-